Skip to content
The Nexus
DossierENTITY

WST

Coverage of WST in the Nexus archive.

Earliest in view: Jul 23 · 10:10 UTCMost recent: Jul 23 · 10:10 UTC
Co-mentioned in this coverage
West Pharmaceutical Servicesorganization1Zacks Investment Researchorganization1Exton, Pennsylvaniaplace1
Recent coverage
  • BUSINESSJul 23 · 10:10 UTCWTOP DC
    West Pharmaceutical: Q2 Earnings Snapshot

    West Pharmaceutical Services Inc. reported Q2 profit of $154 million, or $2.15 per share, with adjusted earnings of $2.37 per share, exceeding analysts' expectations of $2.08 per share. The company also surpassed revenue forecasts with $872.3 million and provided guidance for higher-than-expected earnings and revenue in the current and full-year periods.

WST · Dossier · The Nexus